Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...

However, the traditional intradermal injection ... with intravenous vaccine administration, the researchers designed a double safety switch. The BCG particles are programmed to self-destruct ...

The in-built in protection mechanisms offer a safer and more effective way to combat the deadliest disease of 2024.

Biogen CEO Chris Viehbacher targets subcutaneous Leqembi release for Alzheimers treatment Biogens Chris Viehbacher outlines ...